Alkeus Pharmaceuticals develops innovative therapies aimed at treating serious eye diseases that currently have high unmet needs. Their lead compound, gildeuretinol acetate, is in advanced clinical trials for conditions like Stargardt disease and age-related macular degeneration, providing hope for those affected by these leading causes of blindness.
No jobs found. Subscribe below to get notified when we find something for you.
Searching